Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Transient perforating folliculitis induced by sorafenib
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Delayed onset perforating folliculitis associated with sorafenib
- Hypertrichosis of the pinnae in a patient using panitumumab
- Sodium valproate-aggravated psoriasiform eruption
- Alleviation of alopecia after switching from escitalopram to duloxetine: a case report
- Hair Loss in Patients with Inflammatory Bowel Disease
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Dermatologic adverse effect of subcutaneous furosemide administration in a cat
- Adverse Effects and Drug Interactions of Biologic Agents
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Dermatological drugs and topical agents
- Dermatological Drugs, Topical Agents, and Cosmetics
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- Dermatological adverse events with taxane chemotherapy
- Novel Drugs Targeting Retinoic Acid Receptors
- Actualización terapéutica en corticoesteroides tópicos: clasificación, usos clínicos y efectos colaterales
- Management of Dermatologic Toxicities
- Dermatologic Adverse Events from Cancer Treatments
- Efectos adversos dermatológicos con uso de litio
- Adverse health effects of androgen use
- Adverse cutaneous effects of psychotropic medications
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Dermatological Changes during Menopause and HRT: What to Expect?
- [Dermatologic therapy unit anti-androgens].